Skip to main content
TOVX logo

TOVX

Theriva Biologics, Inc.

$0.24

1.17%

Trade Ideas Performance

Latest Closed Trade Idea

$0.24

1.17%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

3

Social

15

About

Events of Theriva Biologics, Inc. (TOVX)

In October 2025, Theriva Biologics announced a warrant inducement agreement and presented data from the VIRAGE trial. November 2025 saw the report of Q3 2025 results and an updated cash runway into Q1 2027. In February 2026, SYN-020 was licensed to Rasayana Therapeutics. March 2026 included reporting full-year 2025 results, a positive FDA meeting regarding VCN-01, and Rare Pediatric Drug Designation for VCN-01, leading to a stock surge. April 2026 involved announcing an upcoming presentation of VIRAGE trial data, also causing the stock to surge, and a request for shareholder approval of warrant shares. May 2026 saw the report of Q1 2026 results, with the stock price declining by 7.09% in the two weeks leading up to May 8, 2026.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
Theriva Biologics, Inc. (TOVX) Live Stock Price, Chart & Financial News | Edge Hound